whiplash
Two CDC labs won’t close after all

David Goldman/AP
The staff of two world-class CDC labs that were slated for closure have been informed that their terminations were cancelled, STAT’s Helen Branswell reports. Last Thursday, the 55 full-time employees of the CDC’s sexually transmitted disease lab and the viral hepatitis lab received emails about the reversal from the same human resources account that had originally notified them of their dismissals.
They represent a fraction of roughly 450 CDC workers whose firings have reportedly been reversed. “It’s great news,” one of the lab’s employees said. But the relief is tempered with uncertainty over what the working conditions will be, and if more cuts could happen again in the future. “This has been very grueling,” another employee said. Read more from Helen.
pregnancy
The latest data on fetal mortality
There were 20,005 fetal deaths at or after 20 weeks of pregnancy in the U.S. during 2023, according to the latest data from the CDC’s National Center for Health Statistics. That translates to a rate of 5.53 deaths per 1,000 live births, which is not significantly different from the rate in 2022 (5.48). But early fetal deaths (between 20-27 weeks of gestation) increased 4% from the previous year, marking the first statistically significant increase in that annual rate since 2014.
The term “fetal death” is used to include a range of experiences including stillbirth, spontaneous abortion, and miscarriage. The fetal mortality rate was highest in 2023 for Native Hawaiian, Pacific Islander, and Black parents, while Asian parents had the lowest rate.
The data reminded me of a STAT story published the same year as it represents — in 2023, contributor Eleanor Cummins wrote about how pathologists who study pregnancy loss were worried about pressure from law enforcement in the post-Dobbs era to produce definitive cause of death determinations. But it’s not that easy. “There is no such thing as absolute determination,” physician-scientist Mana Parast said. “If anyone said so, they’re lying.” Revisit the story.
funding
Private equity comes to a Harvard research lab
As Harvard University grapples with the Trump administration’s severe funding cuts, a private equity firm has stepped in to finance one of the school’s biological research labs, while also launching a biotech alongside it to develop new therapies for metabolic conditions.
It’s a relatively modest deal in the scope of investment banking, STAT’s Allison DeAngelis reports. But the collaboration provides much-needed capital at a time when the model for funding scientific research has been thrown into chaos. And some university officials believe the unusual arrangement could be at least one model to fund other academic research in the future. Read more on the details.